Systemic inflammation has long been related with adverse survival outcomes in cancer patients, and its biomarkers, such as the Neutrophil-to-Lymphocyte Ratio (NLR), are recognized as poor prognostic indicators. | New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer